- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/21 - Interferons
Patent holdings for IPC class A61K 38/21
Total number of patents in this class: 2278
10-year publication summary
|
192
|
189
|
172
|
177
|
152
|
163
|
223
|
171
|
150
|
32
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
32 |
| IBC Pharmaceuticals, Inc. | 99 |
31 |
| Centre National de La Recherche Scientifique | 9632 |
25 |
| Biogen MA Inc. | 926 |
21 |
| Bristol-myers Squibb Company | 5080 |
20 |
| Gilead Sciences, Inc. | 1879 |
20 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
20 |
| ILC Therapeutics Ltd | 28 |
18 |
| Toray Industries, Inc. | 6652 |
17 |
| Eiger BioPharmaceuticals, Inc. | 61 |
17 |
| Modernatx, Inc. | 1181 |
17 |
| Vib VZW | 799 |
17 |
| ellennbe GmbH | 20 |
17 |
| Universiteit Gent | 1276 |
16 |
| Enanta Pharmaceuticals, Inc. | 420 |
15 |
| Iovance Biotherapeutics, Inc. | 301 |
15 |
| F. Hoffmann-La Roche AG | 7958 |
14 |
| Mayo Foundation for Medical Education and Research | 2981 |
14 |
| Superlab Far East Limited | 21 |
14 |
| Enyo Pharma | 49 |
14 |
| Other owners | 1904 |